Platelet function studies in coronary artery disease. VII. Effect of aspirin and tachycardia stress on aortic and coronary venous blood.
The effects of orally administered aspirin (650 mg) on platelet aggregation patterns and counts in aortic and coronary venous blood were evaluated in patients with coronary artery disease. Studies were conducted at rest and during the stress of tachycardia. Before administration of aspirin, platelet aggregation and counts were lower (p less than 0.01) in coronary venous blood than in aortic blood. The stress of tachycardia resulted in increased (p less than 0.01) platelet aggregation only in coronary venous blood. After administration of aspirin, differences in platelet aggregation and counts between coronary venous and aortic blood at rest were eliminated, and the tachycardia-associated increase in coronary venous blood platelet aggregation was significantly reduced. These observations suggest that aspirin influences and abolishes the changes that occur in blood platelet function as platelets traverse the atherosclerotic myocardial vascular bed. The absence of an increase in platelet aggregation during the stress of tachycardia after administration of aspirin may have important pathophysiologic and therapeutic implications.
D000328:Adult; D000787:Angina Pectoris / Q000209:etiology; D001011:Aorta / Q000187:drug effects / Q000503:physiopathology; D001241:Aspirin / Q000008:administration & dosage*; D003327:Coronary Disease / Q000097:blood* / Q000150:complications; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D010974:Platelet Aggregation; D010976:Platelet Count; D010979:Platelet Function Tests; D013610:Tachycardia / Q000150:complications*; D013997:Time Factors
D001241:Aspirin